Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy

Pediatric Blood and Cancer

Volumn 55, Issue 4, 2010, Pages 690-697

  Geenen, M M ^a,b   Bakker, P J M ^a,c   Kremer, L C M ^a   Kastelein, J J P ^c   Leeuwen, F E Van ^a,d  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

ALL; Late effects; Wilms tumor survivors

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOGONADISM; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEPHROBLASTOMA; OBESITY; PRIMARY TUMOR; PRIORITY JOURNAL; RISK FACTOR; SIBLING; ADOLESCENT; BLOOD; CHILD; INFANT; KIDNEY TUMOR; MORTALITY; NEWBORN; PRESCHOOL CHILD; PREVALENCE; SURVIVOR;

LIPID;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY NEOPLASMS; LIPIDS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREVALENCE; RISK FACTORS; SURVIVORS; WILMS TUMOR;

EID: 77957022763     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22518     Document Type: Article

References (40)

1. Lukens JN. Progress resulting from clinical trials. Solid tumors in childhood cancer. Cancer 1994; 74: 2710-2718.
2. Meadows AT, Black B, Nesbit MEJ, et al. Long-term survival. Clinical care, research, and education. Cancer 1993; 71: 3213-3215.
3. Mertens A, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study. J Clin Oncol 2001; 19: 3163-3172.
4. Möller TR, Garwicz S, Barlow L, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: A population-based study in the Nordic Countries. J Clin Oncol 2001; 19: 3173-3181.
5. Geenen MM, Cardous-Ubbink MC, Kremer LC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. J Am Med Assoc 2007; 297: 2705-2715.
6. Stewart JR, Fajardo LF. Radiation-induced heart disease: An update. Prog Cardiovasc Dis 1984; 27: 173-194.
7. Adams MJ, Hardenbergh PH, Constine LS, et al. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 2003; 45: 55-75.
8. Doll DC. Vascular toxicity associated with antineoplastic agents. Semin Oncol 1995; 19: 580-596.
9. Meinardi MT, Gietema JA, Van Veldhuisen DJ, et al. Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat Rev 2000; 26: 429-447.
10. Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys 2000; 46: 1239-1246.
11. Kantor AF, Li FP, Janov AJ, et al. Hypertension in long-term survivors of childhood renal cancers. J Clin Oncol 1989; 7: 912-915.
12. Talvensaari KK, Lanning M, Tapanainen P, et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 1996; 81: 3051-3055.
13. Gleeson HK, Darzy K, Shalet SM. Late endocrine, metabolic and skeletal sequelae following treatment of childhood cancer. Best Pract Res Clin Endocrinol Metab 2002; 16: 335-348.
14. Stava CJ, Jimenez C, Vassilopoulos-Sellin R. Endocrine sequelae of cancer and cancer treatment. J Cancer Surviv 2007; 1: 261-274 [Epub November 20, 2007].
15. Kannel WB, Wolf PA, Garrison RJ. The Framingham Study: An epidemiological investigation of cardiovascular disease. Bethesda, MD: National Heart, Lung, and Blood Institute; 1987 (NIH Publication No. 87-2703).
16. Gurney JG, Ness KK, Sibley SD, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukaemia. Cancer 2006; 107: 1303-1312.
17. Oeffinger KC. Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease? Pediatr Blood Cancer 2008; 50: 462-467, discussion 468.
18. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 2003; 97: 663-673.
19. Heikens J, Ubbink MC, van der Pal HP, et al. Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease. Cancer 2000; 88: 2116-2121.
20. Summary of the second report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). J Am Med Assoc 1993; 269: 3015-3023.
21. Constine LS, Hinkle AS, French CA, et al. Radiation-associated risk factors for premature cardiovascular disease in childhood cancer survivors include accelerated atherosclerosis. Int J Radiat Oncol Biol Phys 2003; 57: S199-S200.
22. Simbre VC, Duffy SA, Dadlani GH, et al. Cardiac toxicity of cancer chemotherapy: Implications for children. Paediatr Drugs 2005; 3: 187-202.
23. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 324: 808-815.
24. Nysom K, Holm K, Lipsitz ST, et al. The relation between cumulative anthracycline dose and late cardiotoxicity in survivors of childhood leukemia. J Clin Oncol 1998; 16: 545-550.
25. Kremer LC, van Dalen EC, Offringa M, et al. Anthracycline-induced clinical heart failure in a cohort of 607 children: Long-term follow-up study. J Clin Oncol 2001; 19: 191-196.
26. Barry E, Alvarez JA, Scully RE, et al. Anthracycline-induced cardiotoxicity: Course, pathophysiology, prevention and management. Expert Opin Pharmacother 2007; 8: 1039-1058.
27. Oeffinger KC, Buchanan GR, Eshelman DA, et al. Cardiovascular risk factors in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2001; 23: 424-430.
28. Mei-Zahav M, Korzets Z, Cohen I, et al. Ambulatory blood pressure monitoring in children with a solitary kidney-A comparison between unilateral renal agenesis and uninephrectomy. Blood Press Monit 2001; 6: 263-267.
29. Talvensaari K, Knip M. Childhood cancer and later development of the metabolic syndrome. Ann Med 1997; 29: 353-355.
30. Shalet SM. Endocrine sequelae of cancer therapy. Eur J Endocrinol 1996; 135: 135-143.
31. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991; 325: 599-605.
32. Oberfield SE, Chin D, Uli N, et al. Endocrine late effects of childhood cancers. J Pediatr 1997; 131: S37-S41.
33. Byrne J, Mulvihill JJ, Myers MH, et al. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med 1987; 317: 1315-1321.
34. Rosen T. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 1993; 129: 195-200.
35. Bulow B, Hagmar L, Eskilsson J, et al. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab 2000; 85: 574-584.
36. Oeffinger KC, Mertens AC, Sklar CA, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. J Clin Oncol 2003; 21: 1359-1365.
37. Gurney JG, Ness KK, Stovall M, et al. Final height and body mass index among adult survivors of childhood brain cancer: Childhood cancer survivor study. J Clin Endocrinol Metab 2003; 88: 4731-4739.
38. Garmey EG, Liu Q, Sklar CA, et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: A report from the Childhood Cancer Survivor Study. J Clin Oncol 2008; 26: 4639-4645.
39. Parsons SK, Skapek SX, Neufeld EJ, et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukaemia. Blood 1997; 89: 1886-1895.
40. Munker R, Cremer P, Fries S, et al. Serum lipids in patients with Hodgkin's disease in complete remission. Acta Oncol 1997; 36: 75-77.